Stock Fundamentals

Company Information

Company Name
Co-Diagnostics, Inc. Common Stock
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US1897631057
CIK: 0001692415
CUSIP: 189763105
Currency: USD
Full Time Employees: 115
Phone: 801 438 1036
Fiscal Year End: December
IPO Date: Jul 12, 2017
Description:

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.

Address:

2401 S. Foothill Drive, Salt Lake City, UT, United States, 84109

Directors & Officers

Name Title Year Born
Mr. Dwight H. Egan Chairman, CEO & President 1953
Mr. Richard David Abbott President 1972
Mr. Brian L. Brown CPA CFO & Company Secretary 1976
Mr. David Nielsen Chief Operating Officer NA
Mr. Dan Bohrer CPA Vice President of Finance & Accounting NA
Mr. Christopher Thurston Chief Technology Officer NA
Mr. Andrew Benson Head of Investor Relations NA
Dr. Mayuranki Almaula Ph.D. Senior Vice President of Overseas Operations & Strategic Alliances NA
Mr. Seth Egan Chief Commercialization Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 20, 2023 Brian Lee Brown N/A Purchase 100.00 $57.00 $5.70K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 1.91M Dec 31, 2025 1.73% $0.00 11.91%
Private Asset Group LLC 41.39K Mar 31, 2026 1.12% $0.01 5.09%
UBS Group AG 7.37K Mar 31, 2026 0.20% $0.00 603.05%
Global Retirement Partners, LLC. 3.00K Dec 31, 2025 0.00% $0.00 0.00%
Goss Wealth Management LLC 200.00 Dec 31, 2025 0.00% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 88.00 Mar 31, 2026 0.00% $0.00 20.55%
Wells Fargo & Co 81.00 Mar 31, 2026 0.00% $0.00 -1.22%
SBI Securities Co Ltd 58.00 Mar 31, 2026 0.00% $0.00 23.40%
JPMorgan Chase & Co 50.00 Mar 31, 2026 0.00% $0.00 127.27%
Heritage Wealth Advisors, LLC 17.00 Mar 31, 2026 0.00% $0.00 0.00%
Western Wealth Management, LLC 17.00 Mar 31, 2026 0.00% $0.00 0.00%
Advisor Group Holdings, Inc. 10.00 Mar 31, 2026 0.00% $0.00 0.00%
Danske Bank A/S. 7.00 Mar 31, 2026 0.00% $0.00 0.00%
HARBOUR INVESTMENTS, INC. 2.00 Mar 31, 2026 0.00% $0.00 0.00%
Citigroup Inc 1.00 Mar 31, 2026 0.00% $0.00 0.00%
Vanguard Fiduciary Trust Co 1.00 Mar 31, 2026 0.00% $0.00 0.00%
State Street Corp 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Ground Swell Capital, LLC 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
Susquehanna International Group, LLP 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
BlackRock Inc 0.00 Mar 31, 2026 0.00% $0.00 -100.00%

Shares Statistics

Shares Outstanding: 3.69M
Shares Float: 3.50M
% Insiders: 360.40%
% Institutions: 953.00%
Short % Float: 9.80%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Extended Equity Market Fund B 83.11K 0.08% ▲ 0.00% Dec 31, 2025
2 Extended Equity Market Fund E 83.11K 0.08% ▲ 0.00% Dec 31, 2025
3 Vanguard Instl Ttl Stck Mkt Index Trust 27.29K 0.02% ▲ 0.00% Aug 31, 2025
4 U.S. Equity Market Fund 20.19K 0.02% ▲ 0.00% Dec 31, 2025
5 U.S. Equity Market Fund B 20.19K 0.02% ▲ 0.00% Dec 31, 2025
6 SSgA U.S. Total Market Index Strategy 3.13K 0.00% ▼ 1.79% Sep 30, 2025
7 Blackrock Extended Mkt Fund CF 2.77K 0.00% ▼ 96.67% Dec 31, 2025
8 Blackrock US Eq Mkt Fund CF 672.00 0.00% ▼ 96.67% Dec 31, 2025
9 Fidelity Nasdaq Composite Index 39.00 0.00% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $9.28M
Trailing P/E: 0.00
Forward P/E: 15.36

Financial Highlights

Market Cap: $15.81M
EBITDA: $-30.84M
PEG Ratio: $0.00
Book Value: $4.45
Earnings/Share: $-32.26
Profit Margin: 0.00%
Operating Margin: -6,309.12%
ROA (TTM): -52.09%
ROE (TTM): -151.66%
Revenue (TTM): $718.17K
Revenue/Share (TTM): $0.44
Earnings Growth (YOY): 30.80%
Revenue Growth (YOY): 190.30%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 3.87x 0.03x 0.17x N/A -0.01x
2024-12-31 4.41x 0.02x 0.15x N/A -0.03x
2023-12-31 10.81x 0.01x 0.10x N/A -0.02x
2022-12-31 23.94x 0.00x 0.07x -1.81x -0.03x
2021-12-31 9.14x 0.05x 0.16x 97.28x 0.13x
2020-12-31 16.83x 0.00x 0.06x 238,249.37x 0.00x
2019-12-31 4.83x 0.00x 0.22x -55.37x 0.00x
2018-12-31 0.45x -1.80x 1.68x -45.33x -0.31x
2017-12-31 7.09x 0.00x 0.17x -14.71x 0.00x
2016-12-31 0.31x -1.13x 3.31x -7.01x -2.06x
2015-12-31 0.15x -0.88x 4.09x -26.17x -0.53x
2014-12-31 1.84x 0.00x 0.47x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CODX.US!